Orange Book product
RIVASTIGMINE TARTRATE EQ 1.5MG BASE
Orange Book ANDA 203148 · MACLEODS PHARMACEUTICALS LTD · Prescription
Key facts
| Proprietary name | RIVASTIGMINE TARTRATE |
|---|---|
| Active ingredients | RIVASTIGMINE TARTRATE |
| Strength | EQ 1.5MG BASE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Application | ANDA203148 |
| Applicant holder | MACLEODS PHARMACEUTICALS LTD |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Aug 22, 2014 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.